独立行政法人国立病院機構九州医療センターは、独立行政法人国立病院機構が運営する医療機関であり、福岡市中央区地行浜に位置する病院。 国立福岡中央病院と国立久留米病院を統合移転して1994年に開設された。福岡ドームに近接する。 九州グループ事務所の所在地でもある。

During the past decade, National Hospital Organization Kyushu Medical Center conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 18 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 11 clinical trials were completed. i.e. 47.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kyushu Medical Center" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kyushu Medical Center" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kyushu Medical Center" are "Rheumatoid Arthritis" (6 trials), "Systemic Lupus Erythematosus" (5 trials), "Idiopathic Pulmonary Fibrosis" (3 trials), "Lupus Erythematosus, Systemic" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "National Hospital Organization Kyushu Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kyushu Medical Center" are "Drug" (47 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (4 trials), "Baricitinib" (3 trials), "Atezolizumab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kyushu Medical Center" are 54 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Kyushu Medical Center". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in National Hospital Organization Kyushu Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kyushu Medical Center, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".